Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.

191.75 2.01 −1.04%
Market cap
$52.8B
P/E
57.8×
Fwd P/E
37.7×
Dividend yield
2.07%
F-score
7/9
Altman Z
1.84
Beneish M
−2.64
Dividend safety
67/100

Becton, Dickinson and Company 8-K filed Apr 9, 2026

Period ended Apr 6, 2026 · Filed · accepted 4:18 PM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits